Atbin Djamshidian

Innsbruck Medical University — Austria

Medicine · Health Sciences

37h-index4.7kcitations158works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(77), Neurological disorders and treatments(56), Obsessive-Compulsive Spectrum Disorders(23), Genetic Neurodegenerative Diseases(22), Autism Spectrum Disorder Research(21)

Publications156 total

Postural orthostatic tachycardia syndrome is the most frequent cardiovascular autonomic disorder following COVID-19 infection or vaccination
Journal of Neurology·2025· 1 citedOpen Access
Simple diameters, accurate stages:a practical approach to HD-ISS staging
Journal of Neurology·2025Open Access
Cognitive changes preceding Parkinson's disease: a systematic review and meta-analysis of prospective population-based studies
Frontiers in Aging Neuroscience·2025Open Access
Temporal Muscle Thickness Correlates with Functional Decline in Huntington's Disease
Movement Disorders·2025Open Access
Optical coherence tomography – A possible biomarker in early huntington’s disease
Neurological Research and Practice·2025· 1 citedOpen Access
Silent destruction: hidden muscle wasting and body decline in early Huntington’s disease
Journal of Neural Transmission·2025· 1 citedOpen Access
Neuropsychiatric disorders in Parkinson’s disease
Therapeutic Advances in Neurological Disorders·2025· 11 citedOpen Access
Neck and mind: exploring emotion processing in cervical dystonia
Frontiers in Neuroscience·2025Open Access
Protocol for olfactory training in persisting COVID-19-associated loss of smell (SMELL): a monocentric randomised controlled trial conducted in Innsbruck
BMJ Open·2025· 1 citedOpen Access
SPBView: An extendable data analysis and combined visualization tool for saccadic eye-movement, pupil size, and blink detection
SoftwareX·2025Open Access
How reducing oxygen-transport may lower the risk of developing Parkinson’s disease
npj Parkinson s Disease·2025Open Access
Serum neurofilament light chain but not serum glial fibrillary acidic protein is a marker of early Huntington’s disease
Journal of Neurology·2025Open Access
Optical Coherence Tomography in Huntington's Disease—A Potential Future Biomarker for Neurodegeneration?
Neurology International·2025Open Access
Olfactory dysfunction as potential biomarker in neurodegenerative diseases: a narrative review
Frontiers in Neuroscience·2025· 9 citedOpen Access
Drug-induced parkinsonism in a patient with DiGeorge syndrome: a case report
Frontiers in Neuroscience·2024· 1 citedOpen Access
Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based Study
Movement Disorders Clinical Practice·2024· 5 citedOpen Access
Pharmacotherapy for behavioural manifestations in frontotemporal dementia: An expert consensus from the European Reference Network for Rare Neurological Diseases ( <scp>ERN</scp> ‐ <scp>RND</scp> )
European Journal of Neurology·2024· 5 citedOpen Access
Objective and subjective cognitive outcomes one year after COVID‐19
Annals of Clinical and Translational Neurology·2024· 1 citedOpen Access
Long‐Term Medication Profiles in Parkinson's Disease under Subthalamic Deep Brain Stimulation: A Controlled Study
Movement Disorders Clinical Practice·2024· 2 citedOpen Access
Impulse Control Disorders in Parkinson’s Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management
CNS Drugs·2024· 18 citedOpen Access
page 1 of 8Next →

Frequent Co-authors

Klaus Seppi(21), Andrew J. Lees(20), Werner Poewe(18), Sean S. O’Sullivan(14), Philipp Mahlknecht(10), Beatrice Heim(9), Bruno B. Averbeck(9), Stefan Kiechl(8), Heike Stockner(7), Florian Krismer(6), Michael Nocker(6), Christoph Scherfler(5), Laura Zamarian(5), Marina Peball(5), Johann Willeit(5), Gregor K. Wenning(5), Icíar Avilés-Olmos(4), Thomas Foltynie(4), Andrew D. Lawrence(4), Kathrin Marini(4)